Skip to main content
logo
Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,687.00
-13.00 (-0.76%)
At close: Sep 9, 2026

Prestige Biologics Ratios and Metrics

Millions KRW. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Jun '25 Jun '24 Jun '23 Dec '22 Dec '21
Market Capitalization
131,169283,797245,391272,542184,546453,181
Market Cap Growth
-52.88%15.65%-9.96%47.68%-59.28%-
Enterprise Value
215,597364,568378,645369,331283,846447,789
Last Close Price
1687.003650.003990.004460.003020.009600.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Jun '25 Jun '24 Jun '23 Dec '22 Dec '21
PS Ratio
7.2822.64113.13156.1111855.95140.44
PB Ratio
1.222.103.422.731.574.24
P/TBV Ratio
1.242.123.462.761.584.31

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Jun '25 Jun '24 Jun '23 Dec '22 Dec '21
EV/Sales Ratio
11.9629.09174.57211.5518235.34138.77

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Jun '25 Jun '24 Jun '23 Dec '22 Dec '21
Debt / Equity Ratio
0.790.682.411.601.010.73
Net Debt / Equity Ratio
0.780.672.001.150.880.39
Net Debt / EBITDA Ratio
-2.95-4.36-6.47-3.62-3.60-1.80
Net Debt / FCF Ratio
91.10-3.82-8.51-1.90-0.87-0.34
Asset Turnover
0.070.050.01-00.03
Inventory Turnover
1.421.280.89-0.000.14
Quick Ratio
0.020.060.340.530.541.59
Current Ratio
0.250.400.600.790.921.93
Return on Equity (ROE)
-29.36%-26.55%-34.26%--44.30%-74.70%
Return on Assets (ROA)
-10.04%-7.52%-7.02%--9.85%-13.05%
Return on Capital Employed (ROCE)
-33.20%-20.10%-17.00%-18.50%-16.20%-15.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Jun '25 Jun '24 Jun '23 Dec '22 Dec '21
Earnings Yield
-27.01%-9.68%-11.97%-14.47%-26.94%-8.69%
FCF Yield
0.71%-8.29%-6.87%-22.11%-64.36%-27.17%
Buyback Yield / Dilution
-41.09%-20.50%-4.32%-13.35%-16.43%-25.46%